Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Top Cited Papers
- 12 February 2006
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 38 (3), 294-296
- https://doi.org/10.1038/ng1749
Abstract
Cardio-facio-cutaneous (CFC) syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. It phenotypically overlaps with Noonan and Costello syndrome, which are caused by mutations in PTPN11 and HRAS, respectively. In 43 individuals with CFC, we identified two heterozygous KRAS mutations in three individuals and eight BRAF mutations in 16 individuals, suggesting that dysregulation of the RAS-RAF-ERK pathway is a common molecular basis for the three related disorders.Keywords
This publication has 14 references indexed in Scilit:
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005
- Germ-line and somatic PTPN11 mutations in human diseaseEuropean Journal of Medical Genetics, 2005
- Guilty as chargedCancer Cell, 2004
- Spectrum of mutations in PTPN11 and genotype–phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndromeEuropean Journal of Human Genetics, 2003
- PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndromeEuropean Journal of Human Genetics, 2003
- Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndromeHuman Genetics, 2002
- Costello syndrome: Report and reviewAmerican Journal of Medical Genetics, 1999
- Cardio‐facio‐cutaneous (CFC) syndrome — a distinct entity? Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndromeClinical Genetics, 1997
- The Noonan-CFC controversyAmerican Journal of Medical Genetics, 1991
- New multiple congenital anomalies/mental retardation syndrome with cardio‐facio‐cutaneous involvement—the CFC syndromeAmerican Journal of Medical Genetics, 1986